Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- Check4 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a minor internal update. The rest of the page content appears unchanged.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA Puerto Rico location entry was updated to use an unaccented spelling (“Rio” instead of “Río”). The page revision version was also updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.5.2 (updated from v3.5.0).SummaryDifference0.0%

- Check55 days agoChange DetectedItaly site entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed. This update is a metadata/version adjustment rather than a content change to the study information.SummaryDifference0.0%

- Check69 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.